By 5paisa 17 Mar 2025
Tata Motors plans to appoint Deloitte Haskins & Sells LLP as its statutory auditors from FY 2027-28, pending regulatory approval. BSR & Co LLP will continue until FY 2026-27. This change reflects the company's commitment to financial governance, with investors awaiting the regulatory process to unfold.
IndusInd Bank has faced issues with its derivatives portfolio, causing a 2.35% drop in net worth by December 2024. The RBI assures depositors of financial stability. HDFC Mutual Fund increased its stake, and the RBI granted CEO Sumant Kathpalia a one-year extension amid these challenges.
Dr. Reddy’s has recalled Levetiracetam 0.75% sodium chloride injection in the U.S. due to incorrect labeling on infusion bags. The company is working with authorities to resolve the issue, and investors are monitoring the potential impact on its U.S. market performance.
KEC International has secured ₹1,445 crore worth of new orders in the Transmission & Distribution sector in India. With YTD order intake reaching ₹20,600 crore, a significant 80% increase, KEC is poised for continued growth in the infrastructure market.
Tata Consultancy Services (TCS) has appointed Sudeep Kunnumal as CHRO Designate, effective March 14, 2025. He will replace Milind Lakkad upon his retirement, as TCS continues to focus on strengthening its human resources strategies and global presence
Investment/Trading in securities market is subject to market risk, past performance is not a guarantee of future performance. The risk of loss in trading and investment in Securities markets including Equities and Derivatives can be substantial.
Disclaimer